Pancreatic Cancer Research

ResearcherCity of HopeActive in the last 2 years

Christopher James LaRocca

Matched on ORCID iD 0000-0002-9808-1405; OpenAlex author ID A5074689132. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 8

  1. Age-Based Left-Digit Bias in the Treatment of Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s12029-026-01459-1↗
  2. Trajectories of health care contact days experienced by decedents who underwent curative-intent surgery for pancreatic cancer. Co-author DOI 10.1093/oncolo/oyag150↗
  3. The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database. Co-author DOI 10.1093/pubmed/fdac118↗
  4. The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With No… Co-author DOI 10.1177/10732748221109991↗
  5. Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer. Co-author DOI 10.18632/oncotarget.24710↗
  6. A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer. Co-author DOI 10.3390/biomedicines6040104↗
  7. Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.ebiom.2016.05.019↗
  8. Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.surg.2015.01.006↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric Hans Jensen · 4 shared papers, 2022–2026 · strength 0.89
  2. Schelomo Marmor · 3 shared papers, 2022–2026 · strength 0.59
  3. David G. Brauer · 2 shared papers, 2026 · strength 0.59
  4. Jacob S. Ankeny · 2 shared papers, 2023–2026 · strength 0.45
  5. Jason W. Denbo · 2 shared papers, 2022–2023 · strength 0.30
  6. M J White · 2 shared papers, 2022–2023 · strength 0.30
  7. Vishal R. Patel · 1 shared paper, 2026 · strength 0.30
  8. Arjun Gupta · 1 shared paper, 2026 · strength 0.30
  9. Whitney Victoria Johnson · 1 shared paper, 2026 · strength 0.30
  10. Qianyun Luo · 1 shared paper, 2026 · strength 0.29
  11. Julia Davydova · 3 shared papers, 2015–2018 · strength 0.27
  12. Susanne Gray Warner · 1 shared paper, 2018 · strength 0.17
  13. Keith M. Wirth · 1 shared paper, 2023 · strength 0.16
  14. Masato Yamamoto · 2 shared papers, 2015–2018 · strength 0.15
  15. Ariella M. Altman · 1 shared paper, 2022 · strength 0.15
  16. Emil Lou · 1 shared paper, 2022 · strength 0.15
  17. Amanda O. Salzwedel · 1 shared paper, 2018 · strength 0.10
  18. Selwyn Maurice Vickers · 1 shared paper, 2015 · strength 0.05
  19. Leonard Armstrong · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.